Clinical cancers contain stem cell-like subpopulations that can be selected by several markers, including a CD44high/CD24− surface phenotype [28], expression of aldehyde dehydrogenase (ALDH1) [29], as well as EPCR [30]. The gene discussed is ALDH1A1; the disease is cancer.